Multicenter collaborative study on the comprehensive collection and utilization of in-hospital real-world data (RWD) on cancer care.

JRCT ID: jRCT1050240136

Registered date:26/09/2024

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: Cancer
• Date of first enrollment: 01/11/2023
• Target sample size: 12000
• Study type: Observational

Outcome(s)

• Primary Outcome: The primary objective is to utilize the hospital cancer registry data and build a comprehensive medical information platform using CyberOncology. The appropriateness and quality of the real-world data (RWD) collected at each facility will be evaluated.

Key inclusion & exclusion criteria

• Age minimum: Not applicable
• Age maximum: Not applicable
• Gender: Both
• Include criteria: Patients undergoing all cancer drug therapies (including postoperative adjuvant therapy and hormone therapy): Mainly solid tumors such as gastrointestinal cancer, lung cancer, breast cancer, gynecological tumors, urological tumors, malignant melanoma, cancer of unknown primary, and rare cancers are included. However, while it is desirable that all chemotherapy patients be selected in order to calculate statistical data within each institution, patient selection will be allowed to change according to the circumstances of each institution.
• Exclude criteria: Patients who are deemed by the researcher to be inappropriate for participation in this study. For example, patients who are receiving medical treatment at other facilities with absolutely no known medical conditions.

Related Information

• Primary Sponsor: Muto Manabu
• Source(s) of Monetary Support: Kyoto University,Prime Research Institute for Medical RWD, Inc.